NOTE TO READERS: When this project lost substantial funding at the end of 2018, I lost the ability to continue publishing criteria-driven news story reviews and PR news release reviews - once the bread-and-butter of the site going back to 2006. The 3,200 archived reviews, while still educational, are getting old and difficult for me to technically maintain on the back end of the website. So I am announcing that I plan to remove these reviews from the site by April 1, 2021. The blog and the toolkit - two of the most popular features on the site - will remain. If you wish to peruse the reviews before they disappear, please do so by the end of March 2021. After that date you may still be able to access them via the Internet Archive Wayback Machine -

Former fed staffer asks: will science finally trump politics on PSA testing?

Posted By


Dr. Kenny Lin writes:

On March 10 and 11, the (U.S. Preventive Services) Task Force will meet in person for the first time in eight months to once again take up prostate cancer and several other topics that were unable to be addressed due to its previous meeting’s cancellation. I no longer work for AHRQ and have had no involvement in planning this meeting. It is my sincere hope, however, that neither the USPSTF nor the federal government will be cowed by the prospect of triggering another political firestorm into soft-pedaling the scientific evidence that PSA testing does more harm than good.

If you need the back story, he provides that as well, either in the body text of his blog or in links.

You might also like


Please note, comments are no longer published through this website. All previously made comments are still archived and available for viewing through select posts.

Charles Hodges MD

March 7, 2011 at 9:24 am

I am really concerned about having the feds decide anything about medicine that keeps us for looking for treatable disease. PSA as a screening tool is not perfect, but it has saved the lives of several younger men that I have tested over the years. My experience would be considered anecdotal, but for the 40 year old fellow with an elevated Psa who turned out to have Prostate cancer and is alive today, it is 100%. I did the test because of his symptoms and his family history.

Gary Schwitzer

March 7, 2011 at 11:22 am

Of course it could be argued that the example you cite is not – technically – a screening example.
Someone with symptoms and with a family history is in a higher risk category.
Screening – by definition – is looking for problems in otherwise seemingly healthy people with no signs of problems.
The semantics are important.